8-K: US Physical Therapy Reports Q1 2026 Results

U.S. Physical Therapy, Inc. announced record first quarter revenue of $198.3 million, a 7.9% increase year-over-year, while reaffirming full-year guidance.

Summary

• U.S. Physical Therapy, Inc. reported first quarter 2026 net revenue of $198.3 million, up 7.9% from $183.8 million in the first quarter of 2025.
• Net income attributable to shareholders was $5.0 million ($0.12 loss per share) for Q1 2026, a decrease from $9.9 million ($0.80 earnings per share) in Q1 2025.
• This decrease in net income was impacted by a $2.0 million loss on the change in fair value of contingent earn-out consideration in Q1 2026, compared to a $4.8 million gain in Q1 2025.
• Adjusted EBITDA, a non-GAAP measure, increased by $0.7 million to $20.2 million in Q1 2026 from $19.5 million in Q1 2025.
• Physical therapy net revenue grew 7.2% to $167.7 million, with patient visits increasing by 6.9% to 1,543,144.
• Industrial Injury Prevention (IIP) revenue increased by 11.8% to $30.6 million.
• The company added 15 and closed 12 clinics in Q1 2026, ending the quarter with 783 clinics.
• Full year 2026 Adjusted EBITDA guidance was reaffirmed at $102.0 million to $106.0 million.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a mixed but generally positive report. While net income and EPS declined due to non-operational factors, revenue growth was strong, and key operational metrics like Adjusted EBITDA improved. The reaffirmation of guidance and expansion of credit facilities are positive indicators.

Positives

• Record first quarter net revenue of $198.3 million, a 7.9% increase year-over-year.
• Physical therapy net revenue increased by 7.2% to $167.7 million.
• Patient visits increased by 6.9% to 1,543,144.
• Industrial Injury Prevention (IIP) revenue saw an 11.8% increase to $30.6 million.
• Adjusted EBITDA increased by $0.7 million to $20.2 million.
• Full year 2026 Adjusted EBITDA guidance was reaffirmed.
• The company completed an expanded and upgraded credit facility of $450.0 million, providing significant capacity for growth.
• The company acquired a 50% interest in an eight-clinic practice and a 70% interest in an IIP business during Q1 2026.

Negatives

• Net income attributable to USPH shareholders decreased to $5.0 million in Q1 2026 from $9.9 million in Q1 2025.
• Loss per share was $0.12 in Q1 2026, compared to earnings per share of $0.80 in Q1 2025.
• Operating results (non-GAAP) decreased slightly to $7.0 million from $7.3 million.
• Physical therapy gross profit margin decreased to 15.8% from 16.6%.
• Corporate expense as a percentage of total revenue increased to 9.2% from 8.8%.

Risks

• Changes in Medicare rules and guidelines and reimbursement or failure of clinics to maintain Medicare certification.
• Potential retroactive reduction in revenue from Medicare and Medicaid.
• Changes in reimbursement rates or payment methods from third-party payors.
• Compliance with federal and state laws and regulations regarding patient privacy and the corporate practice of medicine.
• Competitive, economic, or reimbursement conditions that may require clinic reorganization or closure.
• Impact of termination of hospital affiliation arrangements.
• Impact of future public health crises, epidemics, or pandemics.
• Potential impact of future vaccinations and/or testing mandates on staffing, revenue, and costs.

Future Outlook

Management reaffirmed the full year 2026 Adjusted EBITDA guidance of $102.0 million to $106.0 million. This guidance includes the impact of two previously announced hospital affiliations and the January 1, 2026 Medicare rate increase. The company expects these strategic hospital alliances to be accretive to revenue, EBITDA, and margins. The guidance reflects a phased ramp-up of these affiliations beginning in May 2026.

Management Comments

• Thanking partners and clinical teams for their efforts on behalf of patients and across important initiatives.
• Highlighting initiatives such as partial virtualization of front desk, rollout of ambient-listening technology, remote therapeutic monitoring, and targeted cash-based program expansion.
• Stating these initiatives, along with hospital alliance focus, will bear fruit particularly in the second half of the year.
• Emphasizing the recent completion of an expanded and upgraded credit facility, providing tremendous capacity for continued growth.
• Noting very positive announcements across all initiatives in the first quarter with more good things to come.

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy's Q1 2026 results reflect continued growth in its core physical therapy segment and strong performance in its Industrial Injury Prevention (IIP) services, aligning with broader industry trends of increased demand for outpatient rehabilitation and preventative health services. The company's strategic focus on hospital alliances and technology adoption for efficiency also positions it to navigate evolving healthcare landscapes.

Comparison to Industry Standards

• The reported 7.9% year-over-year revenue growth for Q1 2026 is a solid performance within the outpatient physical therapy sector, which has seen moderate growth driven by an aging population and increased awareness of physical therapy benefits.
• While net income decreased, the increase in Adjusted EBITDA suggests operational efficiency improvements and effective cost management, a key focus for many healthcare providers aiming to maintain profitability amidst reimbursement pressures.
• The company's expansion through acquisitions (e.g., an eight-clinic practice and an IIP business) is a common strategy in the fragmented physical therapy market, aiming for scale and market penetration, similar to competitors like Select Medical Holdings or U.S. Physical Therapy's own historical growth patterns.
• The reaffirmation of full-year guidance indicates management's confidence in sustained performance, which is crucial for investor confidence in a sector sensitive to regulatory changes and economic conditions.

Stakeholder Impact

• Shareholders: Dividend declared, but net income and EPS decreased year-over-year, offset by revenue growth and reaffirmed guidance.
• Employees: Initiatives like ambient-listening technology aim to improve documentation efficiency and allow for more patient-centric interaction, potentially improving work environment.
• Patients: Remote therapeutic monitoring and expansion of cash-based programs aim to facilitate greater adherence and positively impact care and outcomes.
• Partners/Suppliers: Continued focus on hospital alliances and IIP services suggests ongoing collaboration and business relationships.

Next Steps

• Continue integration of newly acquired clinics and businesses.
• Implement and benefit from technological initiatives (virtualization, ambient-listening, remote monitoring).
• Expand hospital alliance footprint.
• Monitor and adapt to changes in Medicare and other third-party payor reimbursement policies.
• Focus on initiatives expected to bear fruit in the second half of the year.

Key Dates

Recommendation

The company demonstrates consistent revenue growth and operational improvements as evidenced by Adjusted EBITDA, but the decline in net income and EPS, coupled with the impact of fair value adjustments, warrants a cautious approach. The reaffirmation of guidance and credit facility expansion are positive, but the explanation for the net income drop and the ongoing risks in the reimbursement environment suggest holding the stock until further clarity on sustained profitability emerges.

Keywords

U.S. Physical Therapy, USPH, Physical Therapy, Outpatient Clinics, Industrial Injury Prevention, Q1 2026 Results, Financial Report, SEC Filing